Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for both the three months and nine months ended …